{"pmid": "12631594", "sentences": {"sent_1": {"Section": "", "text": "EXPERIMENTAL DESIGN : Three human epithelial cancer cell lines were investigated for preclinical study .", "entities": {"entity_1": {"text": "human epithelial cancer cell lines", "class": "Participant", "negation": 0, "UMLS": "C0006826:cancer,", "index": 1, "start": 4}}, "relations": {}}, "sent_2": {"Section": "", "text": "Cells were analyzed for apoptosis and cell cycle characteristics after paclitaxel treatment .", "entities": {"entity_2": {"text": "Cells", "class": "Outcome", "negation": 0, "UMLS": "C0007584:Cells,", "index": 1, "start": 0}, "entity_3": {"text": "apoptosis", "class": "Outcome", "negation": 0, "UMLS": "", "index": 2, "start": 4}, "entity_4": {"text": "cell cycle characteristics", "class": "Outcome", "negation": 0, "UMLS": "", "index": 3, "start": 6}, "entity_5": {"text": "paclitaxel", "class": "Intervention", "negation": 0, "UMLS": "C0144576:paclitaxel,", "index": 4, "start": 10}}, "relations": {}}, "sent_3": {"Section": "", "text": "The Phase I / II clinical trial for non-small cell lung cancer used pulsed low - dose paclitaxel three times / week with the starting dose of 15 mg / m ( 2 ) .", "entities": {"entity_6": {"text": "non-small cell lung cancer", "class": "Participant", "negation": 0, "UMLS": "C0149925:small cell lung cancer,", "index": 1, "start": 8}, "entity_7": {"text": "paclitaxel", "class": "Intervention", "negation": 0, "UMLS": "C0144576:paclitaxel,", "index": 2, "start": 17}, "attribute_1": {"text": "15 mg / m", "class": "measure", "negation": 0, "UMLS": "", "index": 3, "start": 27}}, "relations": {}}, "sent_4": {"Section": "", "text": "Daily thoracic radiotherapy was delivered in 1.8 Gy / fraction to 60-65 Gy for gross disease and to 45 - 58 Gy for microscopic disease .", "entities": {"entity_8": {"text": "Daily thoracic radiotherapy", "class": "Intervention", "negation": 0, "UMLS": "C0034619:radiotherapy,C0817096:thoracic,", "index": 1, "start": 0}, "entity_9": {"text": "1.8 Gy / fraction", "class": "Intervention", "negation": 0, "UMLS": "", "index": 2, "start": 6}, "entity_10": {"text": "gross disease", "class": "Participant", "negation": 0, "UMLS": "C0012634:disease,", "index": 3, "start": 14}, "entity_11": {"text": "microscopic disease", "class": "Participant", "negation": 0, "UMLS": "C0012634:disease,", "index": 4, "start": 23}}, "relations": {}}, "sent_5": {"Section": "", "text": "Timing of radiotherapy was delayed to allow for a minimum of 4 h for cell cycle progression .", "entities": {"entity_12": {"text": "radiotherapy", "class": "Intervention", "negation": 0, "UMLS": "C0034619:radiotherapy,", "index": 1, "start": 2}, "entity_13": {"text": "cell cycle progression", "class": "Outcome", "negation": 0, "UMLS": "C0242656:progression,", "index": 2, "start": 14}}, "relations": {}}}}